ENTITY
JD Health International

JD Health International (6618 HK)

433
Analysis
Consumer Staples • China
JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.
more
•09 Nov 2020 08:58

JD Health (京东偄康) Pre-IPO - Peer Comparison - It's a Close Fight and Competition Is Intensifying

JD Health (JDH HK) is looking to raise about US$3bn in its upcoming Hong Kong IPO. We are hearing that the company is seeking listing approval....

Share
bullish•Ant Group
•08 Nov 2020 10:26

ECM Weekly (8 November 2020) - Ant, Sunac Svcs, Jinke Svcs, Antengene, Gland Pharma, Kalyan Jewel

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bullish•Eisai Co Ltd
•06 Nov 2020 08:00

Eisai: Shares Surge on Positive Review of Drug Candidate; Blockbuster Potential if Approved

Biogen and Eisai have collaborated on the development and commercialisation of Aducanumab, an investigational treatment for Alzheimer’s disease....

Share
•04 Nov 2020 13:21

JD Health Pre-IPO: Peer Comparison Reveals JD Health’s Financials Are Stronger than Competition

This insight compares and contrasts the business models of JD Health vs its competitors Ping An Health and Ali Health. Our analysis reveals that JD...

Share
•02 Nov 2020 10:01

China Healthcare Weekly (Oct.30)

This article summarized major industry viewpoints, companies news and capital market review in healthcare industry in China during the week of Oct.30.

Logo
457 Views
Share
x